Mark Whitacre, Ph.D.
COO & President
of Operations

Current Position

Cypress Systems, Inc, a Fresno CA based biotechnology company, announced that it has promoted Mark E. Whitacre, Ph.D to become the company’s Chief Operating Officer (COO) and President of Operations. Dr. Whitacre joined the executive management team in December 2006 as President of Technology and Business Development for the new east coast office. The company's CEO & President, Paul A. Willis, states that "Mark's extensive biotechnology business experience combined with his selenium research experience fully aligns with the future direction of the company and the continued expansion into fermentation for biotechnology and life science applications."

Cypress Systems, Inc. is a biotechnology company that is headquartered in Fresno, California and that produces and markets nutraceuticals globally. Cypress is established as a major contributor to the field of biotechnology and related life science applications. Its primary field of life science and health research has been established in the area of cancer prevention (colon, lung and prostate) and other various health factors related to selenium supplementation. For example, Cypress has recently expanded the field of research to explore the role that selenium plays as an immune support agent for such immune areas as HIV/AIDS, cancer patients recovering from chemotherapy treatments and general anti-viral support. Organically bound selenium such as Cypress’ flagship product, SelenoExcell® High Selenium Yeast, has been shown to significantly reduce the incidence in a variety of cancers and also to support enhanced immune activity in immune-compromised individuals. Cypress signed an agreement with the National Cancer Institute (NCI) regarding a Clinical Trial Agreement (CTA) on SelenoExcell® in 1998. As a result of this CTA, SelenoExcell® is used as the sole intervention agent in a series of cancer prevention [colon, lung and prostate] and health related trials.

For more information on selenium, cancer prevention medical journal articles, and other subject matter discussed above, visit Cypress' corporate web site:

For contact information for Mark Whitacre, please use his e-mail address instead of via phone because of his travel schedule:

To contact Mark Whitacre, please use e-mail address:

Copyright © 2006-2022 Cypress Systems, Inc. All rights reserved.